Page last updated: 2024-11-02

pilsicainide and Diseases in Twins

pilsicainide has been researched along with Diseases in Twins in 1 studies

pilsicainide: structure given in first source
pilsicainide : A secondary carboxamide resulting from the formal condensation of the amino group of 2,6-dimethylaniline with the carboxy group of (tetrahydro-1H-pyrrolizin-7a(5H)-yl)acetic acid. It is a sodium channel blocker which is used as an antiarrhythmic drug for the management of atrial tachyarrhythmias in Japan.

Diseases in Twins: Disorders affecting TWINS, one or both, at any age.

Research Excerpts

ExcerptRelevanceReference
"Ventricular fibrillation was induced with double extrastimuli applied to the right ventricular outflow tract."1.31[Brugada syndrome occurring in an identical twin: a case report]. ( Fujiki, A; Inoue, H; Mizumaki, K; Nishida, K; Sakabe, M; Sugao, M; Tsuneda, T, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sakabe, M1
Fujiki, A1
Tsuneda, T1
Nishida, K1
Sugao, M1
Mizumaki, K1
Inoue, H1

Other Studies

1 other study available for pilsicainide and Diseases in Twins

ArticleYear
[Brugada syndrome occurring in an identical twin: a case report].
    Journal of cardiology, 2002, Volume: 40, Issue:3

    Topics: Anti-Arrhythmia Agents; Bundle-Branch Block; Diseases in Twins; Electrocardiography; Humans; Lidocai

2002